SCHEMBL251540

SCHEMBL251540

C=CCc1ccc(OS(=O)(=O)O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ ALOX12 P18054 1/20 0.53
▸ MMP2 P08253 1/20 0.43
▸ GAA P10253 2/20 0.42
▸ GLA P06280 1/20 0.42
▸ XDH P47989 1/20 0.40
▸ STS P08842 1/20 0.40
▸ FFAR4 Q5NUL3 1/20 0.39
▸ PPARG P37231 2/20 0.39
▸ PPARD Q03181 2/20 0.39
▸ CNR2 P34972 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH2 P05091 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4296258 0.95 ALDH1A1 (0.49) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL8157006 0.85 ALDH1A1 (0.57) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL27629206 0.81 ALDH1A1 (0.58) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL8523356 0.80 XDH (0.40) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL7910581 0.77 GLA (0.53) GAAGLASTSCISD1CA1
Fluoride SCHEMBL25237517 0.76 CA12 (0.57) ALDH1A1SMN1; SMN2TP53GAAMAPT
SCHEMBL14431584 0.76 CA2 (0.47) TSHRMMP2GAAGLASTS
SCHEMBL28813572 0.76 ALDH1A1 (0.51) ALDH1A1CYP3A4SMN1; SMN2TP53ALOX15
SCHEMBL22717102 0.75 XDH (0.54) ALDH1A1CYP3A4SMN1; SMN2MMP2GAA
Ammonia Solution, Strong SCHEMBL2908474 0.75 GLA (0.52) GAAGLASTSCISD1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118080168-A Coal flotation agent and preparation method thereof 青岛毅霖新材料有限公司 2024-05-28 — — CN claimed
CN-109569890-B Mixed ether-based flotation agent 千石佳业环保(苏州)有限公司 2023-08-11 — — CN claimed
CN-115590038-A Tobacco mosaic virus nucleic acid interferon dispersible oil suspending agent and application thereof 硅羿科技(上海)有限公司(CN) 2023-01-13 — — CN claimed
CN-110325067-B Conductive glove and method for producing same 锦湖石油化学株式会社 2022-04-15 — — CN claimed
US-20210353611-A1 METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2021-11-18 — — US claimed
EP-3852759-A2 METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS Yeda Research and Development Co. Ltd (IL) 2021-07-28 — — EP claimed
CN-113038951-A Method of treating amyotrophic lateral sclerosis 耶达研究及发展有限公司 2021-06-25 — — CN claimed
CN-112335663-A Amide insecticidal composition and application method thereof 河南喜夫农生物科技有限公司 2021-02-09 — — CN claimed
CN-111978485-A Preparation method of surfactant alkylphenol ether sulfonate for improving recovery efficiency 盘锦天诚源科技有限公司 2020-11-24 — — CN claimed
WO-2020058979-A2 METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2020-03-26 — — WO claimed
US-20140274705-A1 FLORAL PRESERVATIVE ECOLAB USA INC. 2014-09-18 — — US claimed
US-20070154976-A1 Method of determining substrate contained in hemoglobin-containing sample DAIICHI PURE CHEMICALS CO., LTD. (JP) 2007-07-05 — — US claimed
EP-1693462-A1 METHOD OF DETERMINING SUBSTRATE CONTAINED IN HEMOGLOBIN-CONTAINING SAMPLE DAIICHI PURE CHEMICALS CO., LTD. (JP) 2006-08-23 — — EP claimed
US-6395825-B1 REACTING TETRACHLOROSILANE OR A TRICHLOROSILANE IN MIXTURE COMPRISING HYDROCHLORIC ACID, NON-POLAR SOLVENT AND ORGANIC SULFATE; COATINGS, PROTECTIVE BARRIERS, ELECTRONICS DOW CORNING CORPORATION 2002-05-28 — — US claimed
US-5443701-A Electrobiochemical analytical method and electrodes YISSUM RESEARCH DEVELOPMENT COMPANY OF HEBREW UNIVERSITY OF JERUSALEM (IL) 1995-08-22 — — US claimed
JP-61044939-A — — None — — JP disclosed
US-20250375505-A1 COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM UNIV CALIFORNIA (US) 2025-12-11 — — US disclosed
EP-0509346-A1 Biocide activator KAO CORPORATION (JP) 1992-10-21 — — EP disclosed
EP-0453086-A2 Biocide activator KAO CORPORATION (JP) 1991-10-23 — — EP disclosed
JP-S6144939-A VINYL CHLORIDE POLYMER COMPOSITION MITSUBISHI KASEI VINYL CO 1986-03-04 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250375505-A1 COMPOSITIONS AND METHODS FOR MODIFYING BILE ACIDS TO REGULATE LIPID AND STEROID METABOLISM CYP27A1, LIPC, CYP46A1 ALDH1A1 1661/4885CYP3A4 832/4885SMN1; SMN2 4332/4885
US-20210353611-A1 METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS SMN1; SMN2, SOD1, OAT ALDH1A1 665/4885CYP3A4 3316/4885SMN1; SMN2 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback